Geron: Home

First-in-class, first-in-clinic,
telomerase inhibitor

Learn about our innovative approach to developing a treatment for cancer

Click here for important information

Geron News

Geron Corporation Reports Second Quarter 2016 Financial Results and Recent Events

Geron Announces Conference Call to Discuss Second Quarter 2016 Financial Results

Geron Announces Issuance of U.S. Patents Related to Imetelstat

Geron 2016 Annual Meeting

Geron Q1 2016 Conference Call

Geron at the 15th Annual Needham Healthcare Conference